Table 1.

Temporal relationship between transfusions and noninfectious adverse outcomes and their rate per components transfused based on National Blood Collection and Utilization Surveys, 2011 to 2015

NameTemporal relationship to transfusionSeverityReaction rate in 2015*Reaction rate as range reported in 2011, 2013, and 2015*
Allergic/urticarial 0-4 h Mild-moderate 1:1 200 1:1 200-1:1 500 
Acute hemolytic (ABO related) 0-24 h Severe 1:200 000 1:200 000-1:500 000 
Acute hemolytic (non-ABO related) 0-24 h Mild-severe 1:105 000 1:105 000-1:125 000 
Anaphylactic 0-1 h Severe 1:30 000 1:30 000-1:42 000 
Delayed serologic 1-28 d Mild 1:5 400 1:5 400-1:8 200 
Delayed hemolytic 1-28 d Mild-moderate 1:22 000 1:19 000-1:23 000 
Febrile nonhemolytic 0-4 h Mild 1:900 1:800-1:1 000 
Hypotensive 0-1 h Mild-moderate 1:11 000 1:11 000-1:18 000 
Posttransfusion purpura 2-14 d Severe 1:57 000 1:57 000-1:100 000 
TACO 0-6 h Mild-severe 1:9 000 1:9 000-1:13 000 
TRALI 0-6 h Mild-severe 1:60 000 1:57 000-1:64 000 
Transfusion-associated dyspnea 0-24 h Mild 1:14 000 1:14 000-1:23 000 
Transfusion-associated graft-versus-host disease 4-30 d Severe (often fatal) 1:13 000 000 1:950 000-1:13 000 000 
NameTemporal relationship to transfusionSeverityReaction rate in 2015*Reaction rate as range reported in 2011, 2013, and 2015*
Allergic/urticarial 0-4 h Mild-moderate 1:1 200 1:1 200-1:1 500 
Acute hemolytic (ABO related) 0-24 h Severe 1:200 000 1:200 000-1:500 000 
Acute hemolytic (non-ABO related) 0-24 h Mild-severe 1:105 000 1:105 000-1:125 000 
Anaphylactic 0-1 h Severe 1:30 000 1:30 000-1:42 000 
Delayed serologic 1-28 d Mild 1:5 400 1:5 400-1:8 200 
Delayed hemolytic 1-28 d Mild-moderate 1:22 000 1:19 000-1:23 000 
Febrile nonhemolytic 0-4 h Mild 1:900 1:800-1:1 000 
Hypotensive 0-1 h Mild-moderate 1:11 000 1:11 000-1:18 000 
Posttransfusion purpura 2-14 d Severe 1:57 000 1:57 000-1:100 000 
TACO 0-6 h Mild-severe 1:9 000 1:9 000-1:13 000 
TRALI 0-6 h Mild-severe 1:60 000 1:57 000-1:64 000 
Transfusion-associated dyspnea 0-24 h Mild 1:14 000 1:14 000-1:23 000 
Transfusion-associated graft-versus-host disease 4-30 d Severe (often fatal) 1:13 000 000 1:950 000-1:13 000 000 
*

Numbers are approximated to the nearest 100s, 1000s, 10 000s, and 100 000s.

Close Modal

or Create an Account

Close Modal
Close Modal